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In the past, if dermatology researchers considered yeasts at
all, it was usually with the intention of eradicating them. Yet
the yeast Saccharomyces cerevisiae has proven to be a
workhorse in many types of research, due to the ease with
which its genome can be manipulated. Two reports in this
issue detail how experiments using yeast mutants can re-
veal the cell biology of proteins common to yeast and
mammalian cells.
The protein studied in both these reports is the yeast
pmr1, a Ca2þ ATPase that sequesters Ca2þ into the Golgi
intracellular organelle. This function allows the Golgi to fulfill
both its well-known role in processing and sorting proteins
and also enables it to participate in cellular signaling. The
Golgi pmr1, and its sister Ca2þ ATPase ATP2A2 (protein
product SERCA2) are capable of concentrating Ca2þ in the
Golgi and endoplasmic reticulum (ER), respectively, to the
250–300 mM range. Since cytosolic-free Ca2þ generally is
found in the 100 nM range, releasing even a minor amount
of the Golgi or ER Ca2þ stores will lead to increases in
cytosolic Ca2þ . As minute increases in cytosolic or nuclear
Ca2þ signal a dazzling array of cellular changes, these
stores therefore act as batteries whose Ca2þ release mod-
ulates a vast number of cellular functions. If the Golgi and
ER Ca2þ stores are the batteries, the Ca2þ ATPases are the
agents that keep these batteries charged. Mutations in
the human homologue of the yeast pmr1, ATP2C1 (protein
product SPCA1), cause the acantholytic skin condition
Hailey–Hailey disease (HHD) (Hu et al, 2000; Sudbrak et al,
2000). Like yeast, the ATP2C1 is localized to the Golgi in
keratinocytes (Behne et al, 2003). Most mammalian cells
seem to use the ER-localized SERCA for Ca2þ homeostasis
and signaling. Yeast lack the SERCA and substitute the
Golgi-localized pmr1 for these functions. Keratinocytes may
be unique in that they may require both the ATP2C1-
dependent and the ATP2A2-dependent Ca2þ stores for
optimum Ca2þ signaling (Hu et al, 2000; Callewaert et al,
2003).
Although related to the better known SERCA, the pmr1
differs in its localization, insensitivity to the SERCA inhibitor
thapsigargin, and ability to transport Mn2þ ions with high
affinity (Sorin et al, 1997). Thus, the pmr1 Ca2þ ATPase has
the additional important ability to transport Mn2þ . Although
the exact structure of the pmr1 has not yet been revealed,
previous experiments and its homology to SERCA predict
that the high affinity Ca2þ binding sites enclosed by trans-
membrane domains M4, M5 and M6 may be important in
the ionic selectivity of this Ca2þ ATPase (reviewed in Ton
and Rao, 2004), and the transmembrane helices M1 and M2
may interact with ATP and prevent Ca2þ backflow to the
cytosol (Sorensen et al, 2004). Though X-ray crystallo-
graphy remains the gold standard, targeted mutations in
yeast also yields important structure/function information, in
a fraction of the time required to perform X-ray crystallo-
graphy.
Both reports use yeast in which the pmr1 has been mu-
tated. The yeast pmr1 mutants used in these studies fail to
concentrate Ca2þ or Mn2þ within the Golgi secretory path-
way, leading to defective protein processing or sorting. In
addition, these yeast pmr1 mutants cannot regulate cyto-
solic Ca2þ or Mn2þ , leading to cellular toxicity. Research-
ers have exploited these properties and have developed
simple and quick assays whereby pmr1 function can be
assessed by yeast colony growth and survival in the face of
cytosolic or organelle stress caused by raising extracellular
Ca2þ or Mn2þ , or induced by exposing cells to the chelator
BAPTA. Both reports use these assays to test whether cal-
cineurin inhibition might correct defective growth (Szigeti
and Kellermayer, 2004) and to determine that the membrane
helices M4, M5 and M6 are central to ion transport and
Ca2þ /Mn2þ selectivity (Ton and Rao, 2004).
Each report also addresses more immediately clinical
relevant questions. Szigeti and Kellemayer test whether the
partial clearing seen in HHD after treatment with tacrolimus
or cyclosporine is due not to immunologic mechanisms, but
instead to these agents’ ability to inhibit calcineurin. They
find that cyclosporine-induced calcineurin inhibition induc-
es tolerance to high extracellular Ca2þ in a pmr1D mutant.
This tolerance depends on the activation of the vacuolar
Ca2þ /Hþ exchanger VCX1. Thus, calcineurin inhibition may
offer an additional therapeutic approach to treatment of
HHD skin lesions, although, as the authors note, it will not
treat the additional processing defects seen in HHD. Ton
and Tao take a different tack, addressing the question of
whether HHD is caused by haploinsufficiency or a dominant
negative mechanism. The authors tested whether mutant
ATP2C1 could suppress normal pmr1 by overexpressing six
different ATP2C1 mutations in normal yeast that express the
wild-type pmr1. None of the transfected yeast show any
phenotypic changes characteristic of loss of pmr1 function
and the authors therefore conclude that haploinsufficiency
is the likely basis for HHD.
Using yeast to probe human keratinocyte ATP2C1 is a
valid approach only if yeast pmr1 and human ATP2C1
function similarly. Although ATP2C1 shares only 49% amino
acid sequence identity with pmr1, the transmembrane do-
mains known to be important for transport are almost com-
pletely conserved between the two transporters (Ton et al,Abbreviation: HHD, Hailey–Hailey disease
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2002). Moreover, expressing the human ATP2C1 in yeast
fully rescues yeast pmr1 phenotypes from hypersensitivity
to Ca2þ chelators and Mn2þ toxicity (Ton et al, 2002). Thus,
it seems to be valid to use yeast pmr1 to study at least
selected aspects of ATP2C1 function.
These studies leave many unanswered questions. How,
for example, does abnormal Ca2þ or Mn2þ transport lead
to the acantholytic clinical phenotype seen in HHD? Which
is more clinically important, the defects in Ca2þ seques-
tration or the defects in Mn2þ transport? Which clinical mi-
lieu replicates the high extracellular Ca2þ conditions in
which calcineurin inhibitors are effective? The increasing
research interest in keratinocyte ionic signaling, including
recruitment of experimental approaches not previously
applied, is likely to bring new answers to these and other
important questions.
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